Page 13 - Study Design News Today

VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...

VBI Vaccines Inc. announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Companys cancer vaccine immunotherapeutic candidate in...

As consumer interest in natural extracts grows, a clinical study highlights the effectiveness of an allergen-free herbal treatment for acne vulgaris.

Results of a Phase 1, Open-label,Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction -...

Comparison of prostate cancer mortality rate conducted on subjects with a single invitation for PSA screening.

Data highlighted in oral presentation at World Vaccine Congress 2024 on April 3, 2024 Early data from patients eligible for evaluation at week 12 show two observations of stable disease,...

Future Market Insights projects that the paediatric clinical trials market sales will grow at a 5.3% annual pace between 2022 and 2032. From a projected US$ 15 billion in 2021 to a total valuation of US$ 26.47 billion by 2032, this market is anticipated to increase. The increase of chronic illnesses and genetic prob...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Feb 27, 2024--

Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The

Sofwave Medical Ltd. announced clearance by the U.S. Food and Drug Administration for the Companys 510 premarket notification submission for the improvement of the appearance of skin laxity on the...